LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

2022255 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Cell Metabolism

Volume 34, Issue 9, pp. 1234-1247.e9

Field-Weighted Citation Impact: 32.79